Federal Register / Vol. 62, No. 237 / Wednesday, December 10, 1997 / Notices 65083

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 beginning at

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.bog.frb.fed.us for an electronic

announcement that not only lists

applications, but also indicates

procedural and other information about

the meeting.

Dated: December 5, 1997.

William W. Wiles,

Secretary of the Board.

[FR Doc. 97–32394 Filed 12–5–97; 4:27 pm]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency For Health Care Policy And

Research

Contract Review Meeting

In accordance with Section 10(a) of

the Federal Advisory Committee Act (5

U.S.C. Appendix 2), the Agency for

Health Care Policy and Research

(AHCPR) announces the following

technical review committee to meet

during the month of December 1997:

Name: Technical Review Committee for

the AHCPR User Liaison Program

Dissemination Support Contracts.

Date and Time: December 17–18, 1997,

9:00 a.m.–5:00 p.m.

Place: Agency for Health Care Policy and

Research, Executive Office Building, 6th

Floor (East Wing) Conference Rooms, Room

2 on December 17; Room 1 on December 18,

2101 East Jefferson Street, Rockville, MD

20852.

This meeting will be closed to the public.

Purpose: The Technical Review

Committee’s charge is to provide, on behalf

of the AHCPR Contracts Review Committee,

recommendations to the Administrator,

AHCPR, regarding the technical merit of

contract proposals submitted in response to

a specific Request for Proposals for the User

Liaison Program (ULP) Dissemination

Support contracts.

The purpose of these contracts is to

provide for the timely and effective

transmission of relevant health services

research findings and related descriptive and

programmatic information to a broad

spectrum of selected public and private users

of health services research to assist them in

managing more effectively the problems and

issues that confront them with respect to the

design, delivery, quality, evaluation, and

financing of health services. In performance

of these contracts, the contractors shall plan,

develop, and conduct workshops, seminars,

and meetings and prepare research syntheses,

background papers, or technical assistance

documents on health policy issues for

selected target audiences. The target

audiences of users of health services research

include state and local officials; health care

consumers, purchasers, plans, practitioners,

and policymakers (including Federal

executive branch officials). In planning and

conducting workshops, the contractors will

be responsible for not only conducting

comprehensive and objective assessments of

relevant information, but also for effectively

presenting such information in a manner

which is tailored to the particular needs of

the selected target audience(s).

Agenda: The Committee meeting will be

devoted entirely to the technical review and

evaluation of contract proposals submitted in

response to the above referenced Request for

Proposals. The Administrator, AHCPR, has

made a formal determination that this

meeting will not be open to the public. This

action is necessary to protect the free and full

exchange of views in the contract evaluation

process and safeguard confidential

proprietary information, and personal

information concerning individuals

associated with the proposals that may be

discussed during the meeting. This action is

taken in accordance with section 10(d) of the

Federal Advisory Committee Act, 5 U.S.C.,

Appendix 2, 5 U.S.C. 552b(c)(6), 41 CFR

Section 101–6.1023 and Department

procurement regulations, 48 CFR section

315.604(d).

Anyone wishing to obtain information

regarding this meeting should contact Marcia

Clark, User Liaison Program, Center for

Health Information Dissemination, Agency

for Health Care Policy and Research, 2101

East Jefferson Street, Suite 401, Rockville,

Maryland 20852, 301/594–6668.

Dated: December 3, 1997.

John M. Eisenberg,

Administrator.

[FR Doc. 97–32281 Filed 12–9–97; 8:45 am]

BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Advisory Committee; Science Board to

the Food and Drug Administration;

Formation of a Subcommittee

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing the

formation of a subcommittee of the

Science Board to the Food and Drug

Administration (Science Board). The

subcommittee entitled ‘‘Subcommittee

for Center for Biologics Evaluation and

Research Review’’ has been established

to address scientific issues related to the

research programs conducted by the

FDA’s Center for Biologics Evaluation

and Research. The subcommittee’s

findings will be presented to the

Science Board for full public discussion

at a future meeting.

FOR FURTHER INFORMATION CONTACT:

Susan K. Meadows, Office of Science

(HF–32), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–827–3340.

SUPPLEMENTARY INFORMATION: FDA is

announcing the formation of a

subcommittee of the Science Board.

This subcommittee has been established

to address issues related to the scientific

quality, mission relevance, and

scientific management and leadership of

the research programs conducted by

FDA’s Center for Biologics Evaluation

and Research. The subcommittee will

hold its meeting(s) over the next 3 to 4

months to collect information on

biologics research programs, to conduct

an external peer review of biologics

research for quality and relevance, and

to assess an annual programmatic

prioritization model. The

subcommittee’s findings will be

presented to the Science Board for full

public discussion at a future meeting

that will be announced in the Federal

Register prior to the meeting. This

notice is issued under the Federal

Advisory Committee Act of October 6,

1972 (Pub. L. 92–463 (5 U.S.C. app. 2)).

Dated: December 4, 1997.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 97–32275 Filed 12–9–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Advisory Committee; Science Board to

the Food and Drug Administration;

Formation of a Subcommittee

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing the

formation of a subcommittee of the

Science Board to the Food and Drug

Administration (Science Board). The

subcommittee entitled ‘‘Board of

Scientific Counselors’’ has been

established to address scientific issues

related to the research programs

conducted by the Food and Drug

Administration. The subcommittee’s

findings will be presented to the

Science Board for full public discussion

at future meetings.

FOR FURTHER INFORMATION CONTACT:

Susan K. Meadows, Office of Science